Portugal

Reimbursed Care Access

Portugal has a decriminalised approach to personal drug possession (Law 30/2000) while maintaining statutory control over most classic psychedelics under the national drug schedules (Decree‑Law n.º 15/93). Licensed pharmaceutical psychedelics have begun to enter regulated medical pathways (notably esketamine/Spravato, with Infarmed public‑funding evaluation decisions in 2025), while other compounds remain available only within regulated clinical research or, in practice, via private/off‑label clinic programmes subject to medical oversight and no routine public reimbursement.